Harrow Net Invested Capital vs Retained Earnings Analysis
HROW Stock | USD 17.22 0.73 4.43% |
Harrow Health financial indicator trend analysis is much more than just examining Harrow Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harrow Health is a good investment. Please check the relationship between Harrow Health Net Invested Capital and its Retained Earnings accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.
Net Invested Capital vs Retained Earnings
Net Invested Capital vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harrow Health Net Invested Capital account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.
The correlation between Harrow Health's Net Invested Capital and Retained Earnings is -0.78. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Harrow Health, assuming nothing else is changed. The correlation between historical values of Harrow Health's Net Invested Capital and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Harrow Health are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Net Invested Capital i.e., Harrow Health's Net Invested Capital and Retained Earnings go up and down completely randomly.
Correlation Coefficient | -0.78 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Harrow Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 736 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.73 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 54.3M | 63.2M | 90.6M | 95.1M | Total Revenue | 72.5M | 88.6M | 130.2M | 136.7M |
Harrow Health fundamental ratios Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 59.1M | 57.5M | 98.3M | 157.0M | 311.8M | 327.3M | |
Other Current Liab | 2.4M | 2.3M | 4.3M | (836K) | 27.0M | 28.4M | |
Total Current Liabilities | 12.3M | 10.8M | 9.7M | 18.6M | 49.3M | 51.8M | |
Total Stockholder Equity | 27.7M | 27.2M | 11.3M | 27.2M | 70.4M | 73.9M | |
Net Debt | 16.2M | 19.4M | 35.8M | 7.9M | 116.4M | 122.2M | |
Retained Earnings | (74.0M) | (77.4M) | (95.4M) | (109.5M) | (133.9M) | (127.2M) | |
Cash | 4.7M | 4.1M | 42.2M | 96.3M | 74.1M | 77.8M | |
Cash And Short Term Investments | 29.9M | 32.6M | 50.7M | 96.3M | 82.8M | 86.9M | |
Common Stock Shares Outstanding | 26.5M | 25.9M | 26.8M | 27.5M | 32.6M | 34.2M | |
Liabilities And Stockholders Equity | 59.1M | 57.5M | 98.3M | 157.0M | 311.8M | 327.3M | |
Other Stockholder Equity | 101.7M | 104.6M | 106.7M | 136.7M | 204.6M | 214.9M | |
Total Liab | 31.7M | 30.6M | 87.4M | 130.1M | 241.8M | 253.8M | |
Total Current Assets | 36.8M | 40.1M | 60.7M | 118.3M | 139.1M | 146.0M | |
Short Long Term Debt Total | 21.0M | 23.5M | 78.0M | 104.2M | 190.5M | 200.0M | |
Other Current Assets | 786K | 951K | 1.3M | 22.0M | 9.0M | 9.4M | |
Accounts Payable | 7.4M | 3.9M | 5.2M | 18.6M | 21.4M | 22.5M | |
Non Current Liabilities Total | 19.4M | 19.8M | 77.7M | 111.5M | 192.4M | 202.0M | |
Property Plant And Equipment Net | 11.9M | 11.3M | 9.1M | 11.0M | 12.4M | 13.1M | |
Non Current Assets Total | 22.3M | 17.3M | 37.7M | 37.2M | 172.7M | 181.3M | |
Property Plant And Equipment Gross | 11.9M | 11.3M | 16.9M | 20.1M | 20.4M | 21.4M | |
Long Term Debt | 12.2M | 12.4M | 71.7M | 104.2M | 183.2M | 192.3M | |
Net Tangible Assets | 25.0M | 24.9M | (6.2M) | 1.4M | 1.6M | 1.6M | |
Current Deferred Revenue | 57K | 66K | 16K | 113K | 75K | 71.3K | |
Retained Earnings Total Equity | (74.0M) | (77.4M) | (95.4M) | (109.5M) | (98.5M) | (103.5M) | |
Capital Surpluse | 101.7M | 104.6M | 106.7M | 137.1M | 157.6M | 85.0M | |
Short Term Debt | 2.4M | 4.5M | 280K | 723K | 806K | 765.7K | |
Non Currrent Assets Other | 7.7M | 3.8M | 12.4M | 2.0M | (2.1M) | (2.0M) | |
Accumulated Other Comprehensive Income | (2.8M) | (4.4M) | 0.0 | (409K) | (368.1K) | (386.5K) | |
Property Plant Equipment | 5.4M | 4.5M | 3.1M | 3.5M | 4.0M | 3.9M | |
Short Term Investments | 25.2M | 28.5M | 8.5M | 5.6M | 8.7M | 9.9M | |
Net Receivables | 2.7M | 2.7M | 4.5M | 6.4M | 36.5M | 38.3M | |
Long Term Debt Total | 12.2M | 12.4M | 71.7M | 104.2M | 119.8M | 125.8M | |
Capital Lease Obligations | 7M | 7.3M | 6.3M | 8.1M | 7.3M | 4.3M | |
Inventory | 3.3M | 4.0M | 4.2M | 6.5M | 10.9M | 11.4M | |
Non Current Liabilities Other | 7.2M | 7.5M | 6.0M | 7.3M | 8.4M | 8.9M | |
Intangible Assets | 2.3M | 1.9M | 17.1M | 25.8M | 162.0M | 170.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Harrow Health is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.91) | Revenue Per Share 4.089 | Quarterly Revenue Growth 0.325 | Return On Assets (0.02) |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.